Lack of anti-tumor activity with the β-catenin expression inhibitor EZN-3892 in the C57BL/6J Min/+ model of intestinal carcinogenesis
Rian M. Hasson(Dartmouth College), Nancy L. Cho(Brigham and Women's Hospital), Monica M. Bertagnolli(National Institutes of Health), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Jennifer S. Davids(Boston University), Alexandra Briggs(Brigham and Women's Hospital), Adelaide M. Carothers
Cited by 1
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k